AI in Biopharma - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > AI in Biopharma - Global Top Players Market Share and Ranking 2025

AI in Biopharma - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-10-13
Report Id: 2507894
Industry: Pharma & Healthcare
Report Page: 94
Chart: 95

PDF Download

Publication Date: 2025-10-13
Report Id: 2507894
Industry: Pharma & Healthcare
Report Page: 94
Chart: 95

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 AI in Biopharma Definition
1.2 Global AI in Biopharma Market Size and Forecast
1.3 China AI in Biopharma Market Size and Forecast
1.4 Share of China AI in Biopharma Market with Respect to the Global Market
1.5 AI in Biopharma Market Size: China VS Global Growth Rate, 2020-2031
1.6 AI in Biopharma Market Dynamics
1.6.1 AI in Biopharma Market Drivers
1.6.2 AI in Biopharma Market Restraints
1.6.3 AI in Biopharma Industry Trends
1.6.4 AI in Biopharma Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of AI in Biopharma, Global Market Share by Company, 2020-2025
2.2 Global AI in Biopharma Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global AI in Biopharma Concentration Ratio
2.4 Global AI in Biopharma Mergers & Acquisitions, Expansion Plans
2.5 Global AI in Biopharma Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of AI in Biopharma, China Market Share by Company, 2020-2025
3.2 China AI in Biopharma AI in Biopharma Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 AI in Biopharma Industry Chain
4.2 AI in Biopharma Upstream Analysis
4.2.1 AI in Biopharma Core Raw Materials
4.2.2 Main Manufacturers of AI in Biopharma Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 AI in Biopharma Production Mode
4.6 AI in Biopharma Procurement Model
4.7 AI in Biopharma Industry Sales Model and Sales Channels
4.7.1 AI in Biopharma Sales Model
4.7.2 AI in Biopharma Typical Distributors

5 Sights by Type
5.1 AI in Biopharma Classification by Type
5.1.1 Machine Learning (ML) & Deep Learning (DL)
5.1.2 Natural Language Processing (NLP)
5.1.3 Others
5.2 by Type, Global AI in Biopharma Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global AI in Biopharma Consumption Value, 2020-2031

6 Sights by Research Direction
6.1 AI in Biopharma Classification by Research Direction
6.1.1 Drug Discovery & Development
6.1.2 Genomics & Precision Medicine
6.1.3 Medical Imaging & Diagnostics
6.1.4 Others
6.2 by Research Direction, Global AI in Biopharma Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Research Direction, Global AI in Biopharma Consumption Value, 2020-2031

7 Sights by Application
7.1 AI in Biopharma Segment by Application
7.1.1 Drug Development
7.1.2 Disease Diagnosis and Treatment
7.1.3 Other
7.2 by Application, Global AI in Biopharma Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global AI in Biopharma Consumption Value, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global AI in Biopharma Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global AI in Biopharma Consumption Value, 2020-2031
8.3 North America
8.3.1 North America AI in Biopharma Market Size & Forecasts, 2020-2031
8.3.2 By Country, North America AI in Biopharma Market Size Market Share
8.4 Europe
8.4.1 Europe AI in Biopharma Market Size & Forecasts, 2020-2031
8.4.2 By Country, Europe AI in Biopharma Market Size Market Share
8.5 Asia Pacific
8.5.1 Asia Pacific AI in Biopharma Market Size & Forecasts, 2020-2031
8.5.2 By Country/Region, Asia Pacific AI in Biopharma Market Size Market Share
8.6 South America
8.6.1 South AmericaAI in Biopharma Market Size & Forecasts, 2020-2031
8.6.2 By Country, South America AI in Biopharma Market Size Market Share
8.7 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global AI in Biopharma Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global AI in Biopharma Consumption Value, 2020-2031
9.3 United States
9.3.1 United States AI in Biopharma Market Size, 2020-2031
9.3.2 by Type, United States AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.3.3 by Application, United States AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.4 Europe
9.4.1 Europe AI in Biopharma Market Size, 2020-2031
9.4.2 by Type, Europe AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.4.3 by Application, Europe AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.5 China
9.5.1 China AI in Biopharma Market Size, 2020-2031
9.5.2 by Type, China AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.5.3 by Application, China AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.6 Japan
9.6.1 Japan AI in Biopharma Market Size, 2020-2031
9.6.2 by Type, Japan AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.6.3 by Application, Japan AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.7 South Korea
9.7.1 South Korea AI in Biopharma Market Size, 2020-2031
9.7.2 by Type, South Korea AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.7.3 by Application, South Korea AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.8 Southeast Asia
9.8.1 Southeast Asia AI in Biopharma Market Size, 2020-2031
9.8.2 by Type, Southeast Asia AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.8.3 by Application, Southeast Asia AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.9 India
9.9.1 India AI in Biopharma Market Size, 2020-2031
9.9.2 by Type, India AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.9.3 by Application, India AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.10 Middle East & Africa
9.10.1 Middle East & Africa AI in Biopharma Market Size, 2020-2031
9.10.2 by Type, Middle East & Africa AI in Biopharma Consumption Value Market Share, 2024 VS 2031
9.10.3 by Application, Middle East & Africa AI in Biopharma Consumption Value Market Share, 2024 VS 2031

10 Company Profile
10.1 Recursion Pharmaceuticals
10.1.1 Recursion Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.1.2 Recursion Pharmaceuticals Company Profile and Main Business
10.1.3 Recursion Pharmaceuticals AI in Biopharma Models, Specifications, and Application
10.1.4 Recursion Pharmaceuticals AI in Biopharma Revenue and Gross Margin, 2020-2025
10.1.5 Recursion Pharmaceuticals Recent Developments
10.2 Exscientia
10.2.1 Exscientia Company Information, Head Office, Market Area, and Industry Position
10.2.2 Exscientia Company Profile and Main Business
10.2.3 Exscientia AI in Biopharma Models, Specifications, and Application
10.2.4 Exscientia AI in Biopharma Revenue and Gross Margin, 2020-2025
10.2.5 Exscientia Recent Developments
10.3 XtalPi
10.3.1 XtalPi Company Information, Head Office, Market Area, and Industry Position
10.3.2 XtalPi Company Profile and Main Business
10.3.3 XtalPi AI in Biopharma Models, Specifications, and Application
10.3.4 XtalPi AI in Biopharma Revenue and Gross Margin, 2020-2025
10.3.5 XtalPi Recent Developments
10.4 Schrödinger
10.4.1 Schrödinger Company Information, Head Office, Market Area, and Industry Position
10.4.2 Schrödinger Company Profile and Main Business
10.4.3 Schrödinger AI in Biopharma Models, Specifications, and Application
10.4.4 Schrödinger AI in Biopharma Revenue and Gross Margin, 2020-2025
10.4.5 Schrödinger Recent Developments
10.5 Owkin
10.5.1 Owkin Company Information, Head Office, Market Area, and Industry Position
10.5.2 Owkin Company Profile and Main Business
10.5.3 Owkin AI in Biopharma Models, Specifications, and Application
10.5.4 Owkin AI in Biopharma Revenue and Gross Margin, 2020-2025
10.5.5 Owkin Recent Developments
10.6 Evogene
10.6.1 Evogene Company Information, Head Office, Market Area, and Industry Position
10.6.2 Evogene Company Profile and Main Business
10.6.3 Evogene AI in Biopharma Models, Specifications, and Application
10.6.4 Evogene AI in Biopharma Revenue and Gross Margin, 2020-2025
10.6.5 Evogene Recent Developments
10.7 BioNTech
10.7.1 BioNTech Company Information, Head Office, Market Area, and Industry Position
10.7.2 BioNTech Company Profile and Main Business
10.7.3 BioNTech AI in Biopharma Models, Specifications, and Application
10.7.4 BioNTech AI in Biopharma Revenue and Gross Margin, 2020-2025
10.7.5 BioNTech Recent Developments
10.8 MedySapiens
10.8.1 MedySapiens Company Information, Head Office, Market Area, and Industry Position
10.8.2 MedySapiens Company Profile and Main Business
10.8.3 MedySapiens AI in Biopharma Models, Specifications, and Application
10.8.4 MedySapiens AI in Biopharma Revenue and Gross Margin, 2020-2025
10.8.5 MedySapiens Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for AI in Biopharma should grow from US$ 1098 million in 2024 to US$ 2023 million by 2031, with a CAGR of 9.9% for the period of 2025-2031.

AI in Biopharma refers to the application of Artificial Intelligence (AI) and its sub-fields, particularly Machine Learning (ML) and Deep Learning (DL), to transform and accelerate processes across the entire biopharmaceutical value chain. This includes leveraging algorithms to analyze vast and complex biological, chemical, genetic, and clinical datasets to make predictions, recommendations, and automate tasks. The primary goal is to significantly improve the efficiency, speed, and success rate of drug discovery, target identification, compound optimization, clinical trial design, manufacturing, and personalized medicine, ultimately reducing costs and bringing novel therapies to patients faster.

AI in Biopharma

According to YH Research, the global market for AI in Biopharma should grow from US$ 1098 million in 2024 to US$ 2023 million by 2031, with a CAGR of 9.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China AI in Biopharma market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States AI in Biopharma market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Drug Development grew percent to account for percent of the total market sales, and Disease Diagnosis and Treatment grew percent.

This report studies and analyses global AI in Biopharma status and future trends, to help determine the AI in Biopharma market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for AI in Biopharma, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global AI in Biopharma market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global AI in Biopharma by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China AI in Biopharma by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global AI in Biopharma key consuming regions, consumption value and demand structure
(5) AI in Biopharma industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Recursion Pharmaceuticals
Exscientia
XtalPi
Schrödinger
Owkin
Evogene
BioNTech
MedySapiens

Market segment by Type, covers
Machine Learning (ML) & Deep Learning (DL)
Natural Language Processing (NLP)
Others

Market segment by Research Direction, covers
Drug Discovery & Development
Genomics & Precision Medicine
Medical Imaging & Diagnostics
Others

Market segment by Application, can be divided into
Drug Development
Disease Diagnosis and Treatment
Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe AI in Biopharma product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global AI in Biopharma market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China AI in Biopharma market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: AI in Biopharma industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions